Hep Email Update
10 Facts About MASH
Metabolic dysfunction-associated steatohepatitis (MASH) is a serious form of non-alcoholic liver disease.
Denifanstat Shows Promise for Advanced Fatty Liver Disease
People treated with the fatty acid synthase inhibitor saw significant improvements in disease activity, liver fibrosis and MASH resolution.
$13 Million Grant to Advance Liver Cancer Treatment Options
The grant will fund four research projects aimed at improving the efficacy of immunotherapy for liver cancer treatment.
Advertisement
Hepatitis C Survey
Tell us about your experience with hepatitis C.
Closing the Hepatitis C Treatment Gap
Here’s why so few Americans have been cured of hep C—and how we can do better.
How to Get Hepatitis C Treatment
Tips for people with hep C and for providers.
Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2024 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.